KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Cash from Investing Activities (2016 - 2025)

Inovio Pharmaceuticals (INO) has disclosed Cash from Investing Activities for 16 consecutive years, with -$58189.0 as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 100.17% to -$58189.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.0 million through Dec 2025, down 86.51% year-over-year, with the annual reading at $14.0 million for FY2025, 86.51% down from the prior year.
  • Cash from Investing Activities hit -$58189.0 in Q4 2025 for Inovio Pharmaceuticals, down from $8.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $56.0 million in Q3 2021 to a low of -$275.1 million in Q1 2021.
  • Historically, Cash from Investing Activities has averaged $7.0 million across 5 years, with a median of $16.5 million in 2023.
  • Biggest five-year swings in Cash from Investing Activities: crashed 431.02% in 2021 and later skyrocketed 931.55% in 2022.
  • Year by year, Cash from Investing Activities stood at -$6.5 million in 2021, then surged by 931.55% to $54.0 million in 2022, then plummeted by 63.07% to $19.9 million in 2023, then soared by 73.71% to $34.6 million in 2024, then plummeted by 100.17% to -$58189.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for INO at -$58189.0 in Q4 2025, $8.9 million in Q3 2025, and $5.3 million in Q2 2025.